Nikolaus S. Trede
Nikolaus S. Trede

Century Therapeutics

Senior Vice President, Head of Clinical Development

MD degree, Freiburg University

Supervisor of MD thesis: Radvan Urbanek, magna cum laude

DEA immunology, Institut Pasteur, Paris

Supervisor: Pierre Andre Cazenave

PhD Immunology, Universite Paris VII

Supervisor: Raif Geha, summa cum laude

Residency in Pediatrics, Children’s Hospital Boston

Fellowship in Pediatric Hematology/Oncology, Children’s Hospital and Dana Farber Cancer Institute, Boston

Postdoctoral Fellowship in zebrafish immunology in HHMI lab of Leonard Zon, Children’s Hospital

Academic Appointments

Instructor in Pediatrics, Harvard Medical School

Assistant Professor of Pediatrics, University of Utah Medical School and Huntsman Cancer Institute

Associate Professor of Pediatrics, University of Utah Medical School and Huntsman Cancer Institute

Industry Employment

ARIAD Pharmaceuticals, Boston: Medical Director of Clinical Development

Acetylon Pharmaceuticals, Boston: Senior Medical Director of Clinical Development

Juno Therapeutics/Celgene Corporation/BMS, Seattle: Senior Medical Director of Clinical Development

Century Therapeutics, Seattle/Philadelphia: Senior Vice President of Clinical Development

Career Statement:

Following an academic career with expertise in both Hematology/Oncology as well as immunology with a strong focus on translational research and patient care, I have dedicated myself to bringing new compounds to patients with oncologic and autoimmune diseases in the industry setting.

Since 2016 my interest is centered on cell therapy approaches for patients with high unmet need, using both autologous CAR T, as well as iPSC-derived cell product.

Organized by